ArticleRevista Cuidarte
Barriers and facilitators of medication adherence in the management of Diabetes among the Brazilian Amazon population.
Article in Revista Cuidarte. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Type 2 diabetes Mellitus (T2DM) is a prevalent chronic condition with global impact. Medication adherence is essential for disease control, but it remains a challenge in socially vulnerable contexts such as the Brazilian Amazon. Objective: To identify barriers and facilitators of medication adherence in the management of T2DM in the Amazon population. Materials and Methods: A qualitative, descriptive study was conducted in Iranduba (Amazonas) involving individuals with T2DM and community health workers (CHWs). The World Café method and semi-structured interviews were used. Data were analyzed with the support of ATLAS.ti software, using Thematic Network Analysis. Results: A total of 64 participants were included (47 individuals with T2DM and 17 CHWs). Reported barriers included difficulty remembering medication schedules, adverse effects, limited financial resources, lack of medication availability in primary care, and insufficient professional support. Facilitators included self-management strategies, commitment to treatment, purchasing power, family support, and CHWs' actions. Discussion: Medication adherence in Diabetes is shaped by barriers such as forgetfulness, adverse effects, and limited access to medications, while family support, professional guidance, and personal strategies facilitate treatment. These factors interact and affect self-care. Conclusion: Medication adherence among individuals with T2DM in the Amazon is shaped by intrapersonal, interpersonal, and environmental factors. Culturally adapted strategies, greater professional support, and public policies ensuring medication availability are essential to improving care and preventing complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.